About this document
IKCscore: Predicting NSCLC Immunotherapy Response by Dương Vân is a document available to read on EtoBox.
The study introduces the IKCscore, a novel biomarker derived from tumor microenvironment characteristics, which predicts the efficacy of immunotherapy in patients with non-small cell lung cancer (NSCLC). High IKCscore correlates with an inflamed tumor microenvironment and greater T cell receptor diversity, outperforming traditional biomarkers like PD-L1 and tumor mutation burden (TMB) in predicting treatment responses. The findings suggest that IKCscore could guide personalized therapeutic strategies for ad
- Author
- Dương Vân
- Language
- EN